Article
Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo
13 May 2024
Abstract excerpt
Anti-HSV therapies are only suppressive because they do not eliminate latent HSV present in ganglionic neurons, the source of recurrent disease. We have developed a potentially curative approach against HSV infection, based on gene editing using HSV-specific meganucleases delivered by adeno-associated virus (AAV) vectors. Gene editing performed with two anti-HSV-1 meganucleases delivered by a combination of AAV9,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
